Natriumoxybat Kalceks (Sodium Oxybate)

Sodium Oxybate, the active ingredient in Natriumoxybat Kalceks, is a Gamma‑hydroxybutyrate (GHB) derivative presented as an oral solution for oral administration. It is indicated for the treatment of narcolepsy with cataplexy, helping to consolidate nighttime sleep and reduce cataplexy episodes in affected individuals.

GNH USA supplies Natriumoxybat Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is manufactured under strict quality controls.

Sodium Oxybate is used in the central nervous system depressant class to manage a specific sleep disorder.

- Narcolepsy with cataplexy: Improves nighttime sleep continuity and reduces the frequency of cataplexy attacks. - Excessive daytime sleepiness (narcolepsy): Decreases daytime sleepiness and enhances wakefulness. - Cataplexy episodes: Lowers the number and severity of sudden muscle weakness episodes.

Sodium Oxybate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: Mild to moderate stomach upset. - Headache: Transient cranial pain. - Dizziness: Light‑headed sensation. - Vomiting: Occasional emesis.

Serious or Rare Side Effects: - Respiratory depression: Reduced breathing effort, potentially life‑threatening. - Severe hypotension: Marked drop in blood pressure. - Seizures: Uncontrolled electrical activity in the brain. - Allergic reactions: Rash, itching, or swelling.

When prescribing Sodium Oxybate, several precautions should be observed to ensure patient safety. - Dose titration: Initiate at a low dose and increase gradually under medical supervision. - Alcohol avoidance: Do not consume alcohol while taking this medication. - Driving and operating machinery: May cause drowsiness; avoid hazardous activities until response is known. - Pregnancy and lactation: Use only if clearly needed after risk‑benefit assessment with a physician. - Renal impairment: Adjust dosing in patients with severe renal dysfunction. - Store at ambient temperature: Keep in the original container, protect from moisture and light.

Sodium Oxybate can interact with other substances that affect the central nervous system.

Major Interactions (Avoid): - Alcohol: Additive CNS depression leading to profound sedation. - Opioids: Increased risk of respiratory depression. - Benzodiazepines: Enhanced sedative effect and possible respiratory compromise. - Other CNS depressants: May cause profound sedation and impaired respiration.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs): May alter sleep architecture. - Antihistamines: Can increase drowsiness. - Antihypertensives: Potential additive hypotensive effect.